Joint Stock Company "Farmak"

12 clinical trials · Sponsor

Record	Firm	Date
Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers (NCT05124730)	Joint Stock Company "Farmak"	2021-05-21
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects. (NCT05123976)	Joint Stock Company "Farmak"	2020-10-21
A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus (NCT04682873)	Joint Stock Company "Farmak"	2020-05-15
Fasting Bioequivalence Study of 2 Oral Progesterone Soft Capsules 200 mg in 48 Healthy Female Subjects (NCT05125640)	Joint Stock Company "Farmak"	2019-12-13
Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route (NCT05125627)	Joint Stock Company "Farmak"	2019-08-28
Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers (NCT05124717)	Joint Stock Company "Farmak"	2019-06-25
Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers (NCT05123781)	Joint Stock Company "Farmak"	2019-04-03
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel (NCT04079374)	Joint Stock Company "Farmak"	2018-09-03
Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects. (NCT05125549)	Joint Stock Company "Farmak"	2018-07-12

Every clearance here is in the API, with alerts when new ones post.